During the past decade, Süheyla Karadağ Erkoç conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Süheyla Karadağ Erkoç" #1 collaborator was "Ali Abbas Yılmaz" with 2 trials as a collaborator, "Mustafa Kemal Bayar" with 2 trials as a collaborator, "Bengi Şafak" with 1 trials as a collaborator, "Deniz Balcı" with 1 trials as a collaborator and "Elif Beyza Baskan" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Süheyla Karadağ Erkoç" are "Acute Kidney Injury" (2 trials), "Fluid and Electrolyte Imbalance" (1 trials), "Liver Transplant; Complications" (1 trials) and "Trauma; Complications" (1 trials). Many other conditions were trialed in "Süheyla Karadağ Erkoç" in a lesser frequency.

The vast majority of trials in "Süheyla Karadağ Erkoç" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Süheyla Karadağ Erkoç". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Süheyla Karadağ Erkoç, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Süheyla Karadağ Erkoç, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".